{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T04:21:23Z","timestamp":1773375683075,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3591,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidem. Drug Safe."],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1002\/pds.1071","type":"journal-article","created":{"date-parts":[[2005,1,14]],"date-time":"2005-01-14T20:22:00Z","timestamp":1105734120000},"page":"775-787","source":"Crossref","is-referenced-by-count":33,"title":["National differences in reporting \u2018pneumonia\u2019 and \u2018pneumonia interstitial\u2019: an analysis of the WHO International Drug Monitoring Database on 15 drugs in nine countries for seven pulmonary conditions"],"prefix":"10.1002","volume":"14","author":[{"given":"Linda C.","family":"Koo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles P.","family":"Quesenberry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Higenbottam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverley H.","family":"Forsythe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1002\/pds.1071-BIB1","author":"FDA, CDER","year":"2003","unstructured":"FDA, CDER. Questions and answers on Iressa (gefitinib). May 5, 2003. http:\/\/www.fda.gov\/cder\/drug\/infopage\/iressa\/iressaQ&A.htm"},{"key":"10.1002\/pds.1071-BIB2","author":"Peterson","year":"2002","unstructured":"The safety of AstraZeneca's IRESSA: the US oncology view. http:\/\/www.trends-in-medicine.com, Nov. 2002; 1-4."},{"key":"10.1002\/pds.1071-BIB3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(04)15527-X","volume":"363","author":"McCurry","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/pds.1071-BIB4","volume-title":"Viewpoint, Part I, Watching for Safer Medicines","author":"WHO Uppsala Monitoring Centre","year":"2002","unstructured":"WHO Uppsala Monitoring Centre. Viewpoint, Part I, Watching for Safer Medicines. WHO-UMC: Uppsala, Sweden, 2002."},{"key":"10.1002\/pds.1071-BIB5","volume-title":"The Importance of Pharmacovigilance: Safety Monitoring of Medicinal Products","author":"World Health Organization","year":"2002","unstructured":"World Health Organization. The Importance of Pharmacovigilance: Safety Monitoring of Medicinal Products. WHO: Geneva, 2002."},{"key":"10.1002\/pds.1071-BIB6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","volume":"161","author":"American Thoracic Society\/European Respiratory Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/pds.1071-BIB7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society\/European Respiratory Society","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/pds.1071-BIB8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2559.2002.01421.x","volume":"41","author":"Nicholson","year":"2002","journal-title":"Histopathology"},{"key":"10.1002\/pds.1071-BIB9","year":"2003","unstructured":"International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). MedDRA\u00ae, Medical Dictionary for Regulatory Activities. A registered trademark of the International Federation of Pharmaceutical Manufacturer Associations (IFPMA). Northrop Grumman MSSO (distributors): Reston, VA, 2003."},{"key":"10.1002\/pds.1071-BIB10","volume-title":"Adverse Reaction Terminology","author":"World Health Organization","year":"2001","unstructured":"World Health Organization. Adverse Reaction Terminology. WHO UMC: Uppsala, Sweden, 2001."},{"key":"10.1002\/pds.1071-BIB11","author":"WHO-UMC","year":"2001","unstructured":"WHO-UMC. Information on \u2018The Adverse Reaction Terminology\u2019. December 2001. \u2018http:\/\/www.who-umc.org\/pdfs\/ardguide.pdf\u2019"},{"key":"10.1002\/pds.1071-BIB12","author":"National Cancer Institute","unstructured":"National Cancer Institute. PDQ treatment: non-small cell lung cancer and small cell lung cancer. http:\/\/www.cancer.gov\/ cancerinfo\/pdq\/adulttreatment. Last modified, 9-29-03."},{"key":"10.1002\/pds.1071-BIB13","volume-title":"Manual of Clinical Oncology","author":"Casciato","year":"2000","unstructured":"(eds). Manual of Clinical Oncology (4th edn). Lippincott Williams & Wilkins: Philadelphia, 2000."},{"key":"10.1002\/pds.1071-BIB14","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.1780401016","volume":"40","author":"Kremer","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1002\/pds.1071-BIB15","volume-title":"Current Medical Diagnosis and Treatment","author":"Tierney","year":"2004","unstructured":", (eds). 2004. Current Medical Diagnosis and Treatment (43rd edn). Lange Medical Books: New York, NY, 2004."},{"key":"10.1002\/pds.1071-BIB16","volume-title":"National Pharmacovigilance Systems: Country Profiles and Overview","author":"WHO Uppsala Monitoring Centre","year":"1999","unstructured":"WHO Uppsala Monitoring Centre. National Pharmacovigilance Systems: Country Profiles and Overview (2nd edn). Uppsala Monitoring Centre: Uppsala, Sweden, 1999."},{"key":"10.1002\/pds.1071-BIB17","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1002\/1097-0258(20001215)19:23<3199::AID-SIM621>3.0.CO;2-Q","volume":"19","author":"Evans","year":"2000","journal-title":"Stat Med"},{"key":"10.1002\/pds.1071-BIB18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/oxfordjournals.epirev.a000802","volume":"23","author":"Clark","year":"2001","journal-title":"Epidemiol Rev"},{"key":"10.1002\/pds.1071-BIB19","volume-title":"Modern Epidemiology","author":"Rothman","year":"1998","unstructured":". Modern Epidemiology (2nd edn). Lippincott-Raven: Philadelphia, 1998."},{"key":"10.1002\/pds.1071-BIB20","first-page":"947","volume":"28","author":"Haenszel","year":"1962","journal-title":"JNCI"},{"key":"10.1002\/pds.1071-BIB21","volume-title":"Computer Programs for Epidemiologists","author":"Abramson","year":"1999","unstructured":". Computer Programs for Epidemiologists (3rd edn). Brixton Books: London, 1999."},{"key":"10.1002\/pds.1071-BIB22","volume-title":"Stedman's Medical Dictionary","year":"2000","unstructured":"Stedman's Medical Dictionary (27th edn). Lippincott Williams & Wilkins: New York, NY, 2000."},{"key":"10.1002\/pds.1071-BIB23","first-page":"1064","volume-title":"Harrison's Principles of Internal Medicine","author":"Reynolds","year":"1991","unstructured":"Pneumonia and lung abscess. In Harrison's Principles of Internal Medicine, , , et al. (eds). McGraw Hill: New York, NY, 1991; 1064-1069."},{"key":"10.1002\/pds.1071-BIB24","volume-title":"COSTART The Coding Symbols for Thesaurus of Adverse Reaction Terms","author":"FDA","year":"1995","unstructured":"FDA. COSTART The Coding Symbols for Thesaurus of Adverse Reaction Terms (5th edn). FDA CDER: Rockville, MD, 1995."},{"key":"10.1002\/pds.1071-BIB25","unstructured":"Ministry of Health and Welfare, Pharmaceutical Affairs Bureau, Safety Division (Koseisho Yakumukyoku Anzenka), Iyakuhin Fukusayo Yogosyu 1996 (Adverse Drug Reaction Terminology). Japan: Iyaku Joho Kenkyujo Inc. http:\/\/www. jiho.co.jp\/books\/21955\/ (Japanese site)."}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1071","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.1071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T23:28:09Z","timestamp":1625354889000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.1071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.1071","relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}